Close Menu
Home » Veracyte to Buy Allegro Dx for $21M

Veracyte to Buy Allegro Dx for $21M

Sep 05, 2014
|
staff reporter

NEW YORK (GenomeWeb) – Veracyte announced after the close of the market Thursday that it will acquire Allegro Diagnostics for $7.8 million in cash and $13.2 million in common stock.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Letting Samples Fly

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Layoffs at 23andMe

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Dusty Resistance

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

Science Studies Use Single-Cell RNA Sequencing to Study Cell States, Apply Deep Phenotyping to Pregnancy

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more. 

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Feb
20
Featured Webinar

Advances in NGS Gene Expression Studies to Reduce The Cost of Sequencing

Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.